Officer Dennis Mulroy Files Intent to Sell Additional Shares, Continuing Recent Distribution Trend
ANAB has more than doubled off its 52-week low of $11.402.
Summary
AnaptysBio Officer Dennis Mulroy has filed a Form 144 to sell additional shares, extending a pattern of significant stock sales totaling over $17.3 million in the last three months.
Key Events · Ownership and Investor Activity · ANAB
-
Officer Files Intent to Sell
Officer Dennis Mulroy has filed a Form 144 indicating intent to sell 850 shares of common stock, valued at approximately $51,000.
-
Continuation of Significant Selling Pattern
This filing extends a recent trend of substantial stock sales by Officer Mulroy, who has sold a cumulative total of 319,165 shares for gross proceeds of over $17.3 million in the past three months.
-
Cumulative Sales Exceed 1% of Market Cap
The total value of shares sold by Officer Mulroy over the last three months represents approximately 1.05% of AnaptysBio's current market capitalization.
Analysis · ANAB · Life Sciences
This Form 144 filing indicates Officer Dennis Mulroy's intent to sell a small number of shares, but it is part of a broader, significant pattern of stock sales by the officer. Over the past three months, Mulroy has sold over $17.3 million worth of company stock, representing approximately 1.05% of the company's market capitalization. This ongoing distribution by a key executive could be interpreted negatively by investors, especially following the company's recent spin-off and share repurchase program announcement.
At the time of this filing, ANAB was trading at $56.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.